In addition to providing more accurate renal function estimates, measuring serum creatinine and cystatin simultaneously to generate the novel SI, Cr×eGFRcys, may be an easy-to-use approach for screening skeletal muscle health in patients with advanced-stage CKD. The gene discussed is CST4; the disease is chronic kidney disease.